Biotech enterprises are tipped to tap up private investors as public markets struggle to match last year’s record backing
Houman Ashrafian participated in The Times and Sunday Times Life Sciences Summit in Aberdeen where he highlighted the need for investors to support homegrown life sciences companies through the UK’s stock markets.
View the article
